New hope for polycythemia vera patients who Can't use standard drugs
Disease control
Completed
This Phase 2 study tested a drug called P1101 (ropeginterferon alfa-2b) in 29 Japanese adults with polycythemia vera (PV), a blood disorder that causes too many red blood cells. The participants were people for whom standard treatments are hard to use, such as younger patients or…
Phase: PHASE2 • Sponsor: PharmaEssentia Japan K.K. • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC